Alexander Gintsburg, the director of the Gamaleya Research Institute of Epidemiology and Microbiology, said that the process of confirming the Sputnik V COVID-19 vaccine’s effectiveness against the Omicron variant will take ten days maximum RT reported on Sunday.
However, the institute did confirm that both Sputnik V and Sputnik Light are effective against the Omicron variant; more research is being conducted to make sure of the vaccine’s protection against the virus.
In the same context, Gamaleya Institute is working on updating the vaccine's protocol according to the Russian Direct Investment Fund.
It is worthy to mention, the Director of the Foreign Affairs’ Economic Cooperation Department Dmitry Birichevsky said on Tuesday that the state is expecting World Health Organization (WHO) approval for the Sputnik V COVID-19 vaccine in the first half of 2022.
Birichevsky explained, “We have been actively helping the Russian Direct Investment Fund to promote our vaccine Sputnik V in international markets. This is constant routine work, which requires attention and cooperation with embassies.
He added, “We still hope that the vaccine will be requalified by the WHO at some stage. I think it will be in the first half of next year.”
After that, the Russian official reflected that only one step remained for WHO’s approval, which is the technical paperwork; “It means that business circles can go abroad more calmly knowing that our vaccine is approved not only by 71 countries. I hope that it will be recognized globally, and then the barriers that unfortunately exist at present will be eliminated,” Birichevsky explained.
The Sputnik V vaccine is approved and used in more than 71 countries around the world, and it is under the evaluation of the WHO and the European Medicines Agency (EMA).
Follow the latest news on Google News
